Pharmagreen Biotech Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Revenue	0	0	0	-	-	-
Revenue Growth (YoY)	-29.10%	13.74%	-	-	-	-
Cost of Revenue	0	0	0	-	-	-
Gross Profit	0	0	0	-	-	-
Selling, General & Admin	0.24	0.25	0.47	1.07	0.75	0.49
Operating Expenses	0.24	0.25	0.47	1.07	0.75	0.49
Operating Income	-0.23	-0.25	-0.47	-1.07	-0.75	-0.49
Interest Expense	-0.03	-0.03	-0.12	-0.05	-0.77	-0.67
Currency Exchange Gain (Loss)	-0.03	-0	0	-0.03	0.01	-0
Other Non Operating Income (Expenses)	0.07	-0.73	0	0.22	-3.26	-1.15
EBT Excluding Unusual Items	-0.23	-1.01	-0.59	-0.93	-4.77	-2.31
Asset Writedown	-	-	-	-	-	-0.43
Other Unusual Items	-	0	0.02	0.06	0.24	0.26
Pretax Income	-0.23	-1	-0.57	-0.88	-4.53	-2.48
Earnings From Continuing Operations	-0.23	-1	-0.57	-0.88	-4.53	-2.48
Net Income to Company	-0.23	-1	-0.57	-0.88	-4.53	-2.48
Minority Interest in Earnings	0	0	0	0	0	0.04
Net Income	-0.23	-1	-0.57	-0.88	-4.53	-2.44
Net Income to Common	-0.23	-1	-0.57	-0.88	-4.53	-2.44
Shares Outstanding (Basic)	664	659	467	404	294	82
Shares Outstanding (Diluted)	664	659	467	404	294	82
Shares Change (YoY)	28.47%	41.33%	15.55%	37.46%	257.86%	10.82%
EPS (Basic)	-0.00	-0.00	-0.00	-0.00	-0.02	-0.03
EPS (Diluted)	-0.00	-0.00	-0.00	-0.00	-0.02	-0.03
Free Cash Flow	-0.03	-0.03	-0.07	-0.43	-0.21	-0.61
Free Cash Flow Per Share	-	-	-	-0.00	-0.00	-0.01
Gross Margin	44.90%	50.91%	31.02%	-	-	-
Operating Margin	-7807.69%	-7278.06%	-15810.84%	-	-	-
Profit Margin	-7536.88%	-29454.52%	-18971.82%	-	-	-
Free Cash Flow Margin	-1098.63%	-823.64%	-2462.91%	-	-	-
EBIT	-0.23	-0.25	-0.47	-1.07	-0.75	-0.49
Advertising Expenses	-	0.01	0.04	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.